1. Home
  2. IVDA vs PFSA Comparison

IVDA vs PFSA Comparison

Compare IVDA & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.33

Market Cap

2.9M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

SELL

Current Price

$0.53

Market Cap

2.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IVDA
PFSA
Founded
2003
2009
Country
United States
United States
Employees
32
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IVDA
PFSA
Price
$0.33
$0.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
412.6K
6.4M
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.05
52 Week High
$2.70
$4.22

Technical Indicators

Market Signals
Indicator
IVDA
PFSA
Relative Strength Index (RSI) 63.86 42.63
Support Level $0.23 $0.44
Resistance Level $0.38 $0.66
Average True Range (ATR) 0.03 0.07
MACD 0.01 -0.01
Stochastic Oscillator 79.92 29.57

Price Performance

Historical Comparison
IVDA
PFSA

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: